A detailed history of Ram Investment Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Ram Investment Partners, LLC holds 1,743 shares of JNJ stock, worth $253,937. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,743
Previous 1,688 3.26%
Holding current value
$253,937
Previous $265 Million 4.24%
% of portfolio
0.09%
Previous 0.09%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$155.22 - $162.74 $8,537 - $8,950
55 Added 3.26%
1,743 $276 Million
Q4 2023

Jan 08, 2024

BUY
$145.6 - $158.88 $10,628 - $11,598
73 Added 4.52%
1,688 $265 Million
Q3 2023

Oct 13, 2023

SELL
$155.75 - $174.48 $83,326 - $93,346
-535 Reduced 24.88%
1,615 $252 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $6,482 - $6,976
42 Added 1.99%
2,150 $356 Million
Q1 2023

Aug 14, 2023

SELL
$151.05 - $180.26 $59,060 - $70,481
-391 Reduced 15.65%
2,108 $327 Million
Q4 2022

Aug 14, 2023

BUY
$160.2 - $179.79 $400,339 - $449,295
2,499 New
2,499 $441 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ram Investment Partners, LLC Portfolio

Follow Ram Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ram Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ram Investment Partners, LLC with notifications on news.